查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2152669

腦部PET-MRI系統市場規模、佔有率和趨勢分析報告：按階段、產品、最終用途、地區和細分市場預測（2026-2033年）

Brain PET-MRI Systems Market Size, Share & Trends Analysis Report By Phase (Clinical, Pre-Clinical), By Product (Traditional Systems, Helium Free Systems), By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

全球腦部 PET-MRI 系統市場預計到 2025 年將達到 3.828 億美元，到 2026 年將成長到 4.057 億美元，到 2033 年將成長到 6.101 億美元，2026 年至 2033 年的複合年成長率為 6.0%。

北美市場佔據主導地位，預計2025年將佔全球銷售額的30.0%。正子斷層掃描（PET）主要用於神經病學領域，因為它能夠提供功能、生理和分子層面的高解析度3D影像。 PET掃描儀通常與其他影像技術（尤其是磁振造影MRI）相結合，以確保對解剖結構和病理變化進行精確定位。

磁振造影除了能夠顯示腦部結構外，還能評估生理和代謝方面的情況，例如灌注、水腫、血管供應和功能激活，因此與PET系統聯合使用極具吸引力。由此可見，從MRI和PET混合成像系統獲得的整合數據在提高神經系統疾病診斷的準確性方面發揮著至關重要的作用。

腦部PET-MRI系統透過同時觀察大腦中的生理和生化過程，為多參數神經影像學開啟了新的可能性。因此，在各種醫療機構中引入這些設備已成為日益成長的趨勢。此外，各公司正在進行研究，以評估MRI-PET掃描儀在動物和人類受試者中的有效性。

PET-MRI系統在臨床前腦部造影領域的應用日益廣泛，為新參與企業創造了商機。在全球範圍內，為提高MRI解析度以研究人腦而進行的工作正在不斷加強，這促成了超高解析度7特斯拉掃描儀的研發。這些掃描儀能夠捕捉到比現有7T掃描儀多10倍的細節，比目前大多數醫院廣泛使用的3T掃描儀多50倍以上的細節。這種解析度的提升使得科學家能夠觀察到精細至0.4毫米的fMRI特徵，與目前標準3T fMRI通常的2-3毫米解析度相比，這是一個顯著的進步。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：腦部PET-MRI系統的變數、趨勢與範圍

  • 市場概況及未來展望
  • 市場規模和成長前景
  • 市場動態
  • 腦部PET-MRI系統市場分析工具
    • 波特的分析
    • PESTEL 分析

第4章：腦部PET-MRI系統市場：分階段估算與趨勢分析

  • 腦部PET-MRI系統市場：分階段趨勢分析，2025年及2033年
  • 臨床階段
  • 臨床前

第5章：腦部PET-MRI系統市場：產品特定估算與趨勢分析

  • 腦部PET-MRI系統市場：產品分析，2025年及2033年
  • 常規PET-MRI系統
  • 無氦PET-MRI系統市場

第6章：腦部PET-MRI系統市場：依最終用途分類的估算與趨勢分析

  • 醫院市場：按最終用途分類的波動分析（2025 年和 2033 年）
  • 醫院
  • 診斷影像中心
  • 其他

第7章：腦部PET-MRI系統市場：區域估算與趨勢分析

  • 2025 年和 2033 年腦部 PET-MRI 系統的區域市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • GE Healthcare
    • Bruker
    • Mediso Ltd.
    • MR Solutions
    • Cubresa Inc.
    • Aspect Imaging
簡介目錄
Product Code: GVR-4-68038-851-0

The global brain PET-MRI systems market size was valued at USD 382.8 million in 2025 and is projected to grow from USD 405.7 million in 2026 to USD 610.1 million by 2033, growing at a CAGR of 6.0% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 30.0% in 2025. Positron emission tomography is mainly used in neurology for its ability to provide high-resolution, 3D images of functional, physiological, and molecular targets. PET scanners are frequently integrated with other imaging modalities, particularly MRI, to ensure precise alignment with anatomical structures and pathological alterations.

The combination of MRI and PET is widely recognized as a highly efficient hybrid imaging modality in neurology. The capability of magnetic resonance imaging (MRI) to depict the brain's structure, along with its ability to assess physiological and metabolic aspects such as perfusion, edema, vascular supply, and functional activation, enhances its appeal when used in conjunction with PET Systems. Consequently, the combined data from the MRI and PET hybrid imaging systems play a crucial role in improving the diagnosis of neurological conditions.

PET-MRI systems for the brain have created new possibilities for multiparametric neuroimaging by simultaneously observing the brain's physiological and biochemical processes. Consequently, there is a growing trend of installing these devices in various medical settings. Furthermore, companies are conducting research to assess the efficacy of MRI-PET scanners in both animal and human subjects.

The use of brain PET-MRI systems in preclinical imaging is on the rise, creating opportunities for new market entrants. There has been a significant global push to enhance MRI resolution for studying the human brain, resulting in the development of an ultra-high-resolution 7 Tesla scanner. This scanner can capture up to 10 times more detail than current 7T scanners and over 50 times more detail than current 3T scanners, which are widely used in most hospitals. The enhanced clarity allows scientists to observe fMRI features as small as 0.4 millimeters, compared with the usual 2 or 3 millimeters in the current standard 3T fMRI.

Brain PET-MRI Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global brain PET-MRI systems market report based on phase, product, end use, and region:

  • Phase Outlook (Revenue, USD Million, 2021 - 2033)

Clinical

Pre-clinical

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

Traditional PET-MRI systems

Helium-free PET-MRI systems

  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Hospitals
    • Diagnostic imaging centers
    • Others

Regional Outlook (Revenue, USD Million, 2021 - 2033)

    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Denmark
      • Sweden
      • Norway
    • Asia Pacific
      • China
      • Japan
      • India
      • Thailand
      • South Korea
      • Australia
    • Latin America
      • Brazil
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Brain PET-MRI Systems Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Brain PET-MRI Systems Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Brain PET-MRI Systems: Phase Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Brain PET-MRI Systems: Phase Movement Analysis, USD Million, 2025 & 2033
  • 4.3. Clinical
    • 4.3.1. Clinical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Pre-Clinical
    • 4.4.1. Pre-Clinical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Brain PET-MRI Systems Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Brain PET-MRI Systems Market: Product Analysis, USD Million, 2025 & 2033
  • 5.3. Traditional PET-MRI systems
    • 5.3.1. Traditional PET-MRI systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Helium Free PET-MRI System Market
    • 5.4.1. Helium Free PET-MRI systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Brain PET-MRI Systems Market: End use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Hospitals Market: End use Movement Analysis, USD Million, 2025 & 2033
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Diagnostic Imaging Centers
    • 6.4.1. Diagnostic Imaging Center Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Brain PET-MRI Systems Market: Regional Estimates & Trend Analysis

  • 7.1. Brain PET-MRI Systems Share, By Region, 2025 & 2033, USD Million
  • 7.2. North America
    • 7.2.1. North America Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. India
      • 7.4.3.1. India Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Australia
      • 7.4.4.1. Australia Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Brain PET-MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Siemens Healthineers AG
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Koninklijke Philips N.V.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. GE Healthcare
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Bruker
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Mediso Ltd.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. MR Solutions
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Cubresa Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Aspect Imaging
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives